Employment Type : Full-Time
Reports to: Vice President Business Development
Department: Business Development
Business Unit: Headquarters
Location: New Haven, CT
Company and Job Overview:
BioXcel Therapeutics, Inc. (NASDAQ: BTAI) is a publicly traded, clinical-stage biopharmaceutical company that utilizes novel artificial intelligence, or AI, to identify the next wave of medicines across neuroscience and immuno-oncology.
Job Description
BioXcel Therapeutics, Inc. is focused on drug development that utilizes artificial intelligence to identify improved therapies in neuroscience and immuno-oncology. As we continue to grow and expand its pipeline, we are seeking a qualified a “Sr. Manager/Sr. Analyst Business and Corporate Development” to contribute to the continued growth of the company.
Objectives of this Role
Corporate and BD analytics – conduct analysis on BD and corporate requirements
Licensing activities that include but not limited to identifying, evaluates, and assist in transaction of BD opportunities that meet the strategic scientific, therapeutic, and commercial needs of the organization
Interact with IR/PR firm for corporate messaging
Prepares and presents scientific and business rationale for any recommendations and transaction proposals to senior management for approval
Basic/Minimum Qualifications:
Doctorate degree
OR
Master’s degree and 2 years of (functional area expertise) experience
OR
Bachelor’s degree 4 years of (functional area expertise) experience
Preferred Qualifications:
Graduate degree in business or sciences
Minimum 3 years of biopharma or banking experience
Excellent verbal and written communication skills
Proficiency with data analysis, forecasting
Ability to plan and manage resources
Good interpersonal skills and presentation (both written and verbal) skills
Your Path to Endless Opportunities
If you’re looking to push the envelope and join an innovative company where technology meets drug discovery and development and you’re enthusiastic, creative, with a passion for cutting-edge research, you should join our team! We are looking for highly motivated, passionate employees to help us drive technology solutions for discovering breakthrough treatments for our portfolio of oncology and neuroscience programs, as well as for our partners across major therapeutic areas.
About BioXcel Therapeutics, Inc.
BioXcel Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on drug development that utilizes artificial intelligence to identify improved therapies in neuroscience and immuno-oncology. BTI's drug re-innovation approach leverages existing approved drugs and/or clinically evaluated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices. BTI's two most advanced clinical development programs are BXCL501, an investigational sublingual thin film formulation in development for acute treatment of agitation resulting from neuropsychiatric disorders, and BXCL701, an investigational orally administered systemic innate immunity activator in development for treatment of a rare form of prostate cancer and for treatment of pancreatic cancer in combination with other immuno-oncology agents. For more information, please visit www.bioxceltherapeutics.com.